Insider trades
Stock that executives, directors and 10% owners bought and sold on the open market, from the Form 4s they file with the SEC within two business days. Grants, option exercises and shares sold to cover taxes are left out.
- $291M bought by 68 insiders at 55 companies
- $255M sold by 42 insiders outside a trading plan
- $2.6B sold by 242 insiders under 10b5-1 plans
- 10 companies where two or more insiders bought (30 days)
Biggest buys
Past week, each insider's filings added up.
-
SAFXXCF GlobalEEME Energy SPV I, LLC10% owner$142M
-
CRBGCorebridge FinancialLife Insurance Co Nippon10% owner$62M
-
PAMPampa EnergiaMarcos Marcelo MindlinDirector$35.1M
-
PEPPepsiCoRobert C PohladDirector$23.7M
-
DOLEDole PLCPale Fire Capital SE10% owner, +4 joint filers$8.6M
-
APLDApplied DigitalJason Gechen ZhangPresident$5.7M
-
BORRBorr DrillingTor Olav TroimDirector$2.3M
-
FBKFB FinancialOrrin H Ingram IIDirector$1.5M
-
BORRBorr DrillingHarvey Edward SnowlingCOO$1.5M
-
TENXTenax TherapeuticsADAR1 Capital Management, LLC10% owner, +1 joint filer$1.5M
Biggest sales
Past week, each insider's filings added up. Planned sales are marked.
-
IHTInnSuites Hospitality TrustJames F WirthCEO$2B
-
INSWInternational SeawaysFamatown Finance Ltd10% owner, +2 joint filers$107M
-
SNOWSnowflakeFrank SlootmanDirector$94.9M
-
TALOTalos EnergyEmpresarial De Capitales S.a. De C.v. Control10% owner$85.9M
-
PATHUiPathDaniel DinesCEO$33.1M
-
UTHRUnited TherapeuticsMartine A RothblattCEO$26M
-
MUMicron TechnologyScott J DeboerPres. & Chief Tech & Prod Offr$25.7M
-
NTRANateraMatthew RabinowitzChair$20.1M
-
AFLAflacJapan Post Holdings Co., Ltd.10% owner$19.9M
-
MRNAModernaStephen HogePresident$17M
Cluster buying
Companies where two or more insiders bought on the open market in the last 30 days, most buyers first
-
Che-Chia Wei CEO, Yuh-Jier Mii COO, Yung-Pei Chin COO, Yung-Chin Hou COO, +15 more
-
Reuben S Leibowitz Director, Larry C Glasscock Director, Daniel C. Smith Director, Gary M Rodkin Director, +7 more
-
R Jeffrey Bailly Director, Daniel L Florness Director, Srilata Zaheer Director, Charles T Lauber Director, +5 more
-
Steven M Paul Director, John Maraganore Director, Troy A. Ignelzi CFO, Wendy B. Young Director, +1 more
-
Thomas Jon Hammond Director, Sandip I Patel CFO, John Martin Schaible Chair, David Craig Ridenhour President, +1 more
-
John B Williamson III Director, Robert B Johnston Director, Paul W Nester CEO, Lawrence T. Oliver Senior VP and Secretary, +1 more
-
Michael Jordan Osborn CEO, John Walter Hazlett CFO, Gregory William Voorhies Director, James W Bernau President, +1 more
-
Matthew G De Soto Director, Albert J. Evans Director, Kimberly J Brumbaugh Director, Theodore W Mowery Director, +1 more
-
Smriti Laxman Popenoe CEO, Byron L Boston CEO, Terrence John Connelly Jr. Chief Investment Officer, Michael Andrew Sartori CFO
-
Lewis H Titterton Jr. Director, Amit Kumar CEO, Michael Catelani CFO, Arnold M Baskies Director
IRIX insider trades
Every open-market buy and sale in IRIX, one row per filing, newest first
-
Shih-Yao David Lin 10% ownerIRIXIRIDEXBuy$439K 350,557 shares at $1.25 +42% to stakeTraded Dec 3, 2025–Mar 30 Filed Oct 7
-
Shih-Yao David Lin 10% ownerIRIXIRIDEXBuy$274K 266,068 shares at $1.03 +47% to stakeTraded Jun 6, 2025–Dec 1, 2025 Filed Oct 7
-
Shih-Yao David Lin 10% ownerIRIXIRIDEXBuy$598K 570,184 shares at $1.05 New stakeTraded Mar 25, 2025–Jun 5, 2025 Filed Oct 7
-
Romeo R Dizon CFOIRIXIRIDEXBuy$4,977 7,900 shares at $0.6300 +4.5% to stakeTraded Sep 16 Filed Sep 16
-
Romeo R Dizon CFOIRIXIRIDEXBuy$1,530 2,354 shares at $0.6500 +1.3% to stakeTraded Sep 14 Filed Sep 14
-
Romeo R Dizon CFOIRIXIRIDEXBuy$3,468 5,100 shares at $0.6800 +3% to stakeTraded Sep 10 Filed Sep 10
-
Romeo R Dizon CFOIRIXIRIDEXBuy$4,999 6,668 shares at $0.7500Traded Aug 24 Filed Aug 24
-
Romeo R Dizon CFOIRIXIRIDEXBuy$1,110 975 shares at $1.14 +0.7% to stakeTraded Jun 12 Filed Jun 15
-
Romeo R Dizon CFOIRIXIRIDEXBuy$1,910 1,675 shares at $1.14 +1.3% to stakeTraded Jun 11 Filed Jun 12
-
Romeo R Dizon CFOIRIXIRIDEXBuy$2,688 2,400 shares at $1.12 +1.8% to stakeTraded Jun 8 Filed Jun 9
-
Romeo R Dizon CFOIRIXIRIDEXBuy$2,899 2,521 shares at $1.15 +2% to stakeTraded Jun 5 Filed Jun 8
-
Romeo R Dizon CFOIRIXIRIDEXBuy$2,808 2,400 shares at $1.17 +1.9% to stakeTraded Jun 3 Filed Jun 3
-
Romeo R Dizon CFOIRIXIRIDEXBuy$5,004 5,004 shares at $1.00 +4.1% to stakeTraded May 26 Filed May 26
-
Romeo R Dizon CFOIRIXIRIDEXBuy$1,399 1,110 shares at $1.26 +0.9% to stakeTraded Mar 6 Filed Mar 9
-
Romeo R Dizon CFOIRIXIRIDEXBuy$2,942 2,200 shares at $1.34 +1.9% to stakeTraded Feb 17 Filed Feb 17
-
Romeo R Dizon CFOIRIXIRIDEXBuy$2,145 1,500 shares at $1.43 +1.3% to stakeTraded Feb 12 Filed Feb 12
-
Romeo R Dizon CFOIRIXIRIDEXBuy$1,460 1,000 shares at $1.46 +0.9% to stakeTraded Feb 10 Filed Feb 10
-
Romeo R Dizon CFOIRIXIRIDEXBuy$3,450 2,500 shares at $1.38 +2.2% to stakeTraded Feb 3 Filed Feb 3
-
Romeo R Dizon CFOIRIXIRIDEXBuy$1,588 1,101 shares at $1.44 +1% to stakeTraded Jan 29 Filed Jan 29
-
Romeo R Dizon CFOIRIXIRIDEXBuy$1,898 1,300 shares at $1.46 +1.2% to stakeTraded Jan 28 Filed Jan 28
-
Romeo R Dizon CFOIRIXIRIDEXBuy$5,009 3,385 shares at $1.48 +3.2% to stakeTraded Jan 27 Filed Jan 27
-
Romeo R Dizon CFOIRIXIRIDEXBuy$1,889 1,243 shares at $1.52 +1.2% to stakeTraded Jan 26 Filed Jan 26
-
Romeo R Dizon CFOIRIXIRIDEXBuy$7,716 5,221 shares at $1.48 +5.2% to stakeTraded Jan 23 Filed Jan 23
-
Romeo R Dizon CFOIRIXIRIDEXBuy$6,381 4,259 shares at $1.50 +4.4% to stakeTraded Jan 20–21 Filed Jan 21
-
Romeo R Dizon CFOIRIXIRIDEXBuy$5,006 3,496 shares at $1.43 +3.8% to stakeTraded Jan 16 Filed Jan 16
-
William M Moore DirectorIRIXIRIDEXBuy$2,020 2,000 shares at $1.01 +0.8% to stakeTraded Dec 16, 2025 Filed Dec 18, 2025
-
William M Moore DirectorIRIXIRIDEXBuy— 20,000 shares +8.7% to stakeTraded Dec 15, 2025 Filed Dec 16, 2025
-
William M Moore DirectorIRIXIRIDEXBuy— 30,000 shares +12% to stakeTraded Dec 11–12 Filed Dec 15, 2025
-
Romeo R Dizon CFOIRIXIRIDEXBuy$2,296 2,365 shares at $0.9700 +2.6% to stakeTraded Dec 12, 2025 Filed Dec 15, 2025
-
Romeo R Dizon CFOIRIXIRIDEXBuy$1,498 1,584 shares at $0.9500 +1.8% to stakeTraded Dec 2, 2025 Filed Dec 4, 2025
-
Romeo R Dizon CFOIRIXIRIDEXBuy$5,530 5,760 shares at $0.9600 +6.9% to stakeTraded Nov 20, 2025 Filed Nov 21, 2025
-
Romeo R Dizon CFOIRIXIRIDEXBuy$960 1,000 shares at $0.9600 +1.2% to stakeTraded Nov 19, 2025 Filed Nov 20, 2025
-
Romeo R Dizon CFOIRIXIRIDEXBuy$2,005 2,133 shares at $0.9400 +2.7% to stakeTraded Nov 18, 2025 Filed Nov 19, 2025
-
William M Moore DirectorIRIXIRIDEXBuy$48K 50,000 shares at $0.9700 +25% to stakeTraded Nov 14–17 Filed Nov 18, 2025
-
Romeo R Dizon CFOIRIXIRIDEXBuy$2,999 3,124 shares at $0.9600 +4.1% to stakeTraded Nov 17, 2025 Filed Nov 18, 2025
-
Romeo R Dizon CFOIRIXIRIDEXBuy$13K 14,769 shares at $0.8800 +24% to stakeTraded Nov 14, 2025 Filed Nov 17, 2025
About this data
- Officers, directors and anyone owning more than 10% of a company must report a trade in its stock on a Form 4 within two business days. We read each filing from SEC EDGAR and link to it on every row.
- Only open-market purchases and sales of common stock count here. Stock grants, option exercises, gifts and shares withheld or sold to pay taxes on vesting awards are not decisions to buy or sell, so they are left out.
- A planned sale was made under a Rule 10b5-1 trading plan, which the insider set up months in advance. Many executives sell this way on a schedule, so a planned sale says less than one made on the day.
- Values are shares times the price reported. When a filing amends an earlier one, the amended trades replace the originals. Related owners (a fund and its manager) who report the same trade separately are shown once.
- We cover the 4,838 US companies on our earnings calendar, with a year of history. The superinvestor notes count the featured 13F managers who added or cut the stock in their latest quarter.